Released on: February 26, 2008, 5:45 am

Press Release Author: Molecular Profiles Ltd

Industry: Pharmaceuticals

Press Release Summary: Molecular Profiles, a global leader in the provision of
innovative contract research services to the pharmaceutical, biopharmaceutical and
biomedical sectors worldwide, announces two new significant additions to the team.
Dr. Mike Fanfarillo has joined Molecular Profiles as Operations Director and Dr.
Robert Sherry as Associate Director in Pharmaceutics.

Press Release Body: Molecular Profiles, a global leader in the provision of
innovative contract research services to the pharmaceutical, biopharmaceutical and
biomedical sectors worldwide, announces two new significant additions to the team.
Dr. Mike Fanfarillo has joined Molecular Profiles as Operations Director and Dr.
Robert Sherry as Associate Director in Pharmaceutics.

As Operations Director, Mike Fanfarillo is responsible for the management of
research projects and the development of the technical team,and services at
Molecular Profiles. Mike is also a Study Director on numerous patent related
projects. Mike's expertise covers the range of preparative, analytical and
characterisation techniques used in the pharmaceutical development of medicinal
products, from chromatography to spectroscopy. Mike also has extensive experience
of writing and assembling Drug Product Licence applications, writing Pharmaceutical
Expert Reports and assessment of API Drug Master Files from third party
manufacturers.

Mike graduated in chemistry from the University of Manchester and then completed a
D.Phil in chemistry at the University of Oxford. He has over 20 years' experience in
the pharmaceutical industry having worked for ICI/Zeneca Pharmaceuticals, Boots
Healthcare International and Reckitt Benckiser Healthcare International.

In his role as Associate Director in Pharmaceutics, Bob Sherry is an expert in a
wide range of product dose forms, consulting on a range of formulation issues facing
pharmaceutical companies in the development of their products, including utilizing
outputs from investigations to assert intellectual property rights for these
clients. Bob is also responsible for directing technical studies to resolve complex
formulation issues and for developing collaborations with academic and industrial
experts. Bob has particular experience of regulatory requirements for new licence
submissions, clinical trials manufacture and significant patent experience, with
several formulation and process patents granted.





Bob received his PhD in physical chemistry from Leicester University, where he used
a number of spectroscopic and analytical techniques to study reaction kinetics. He
has over 20 years of industrial experience at Boots Healthcare International
covering a wide range of formulation types and product formats.

"We are delighted to announce these two new appointments as an expansion to our
team", comments Dr. Nikin Patel, CEO, Molecular Profiles. "Following on from the
recent successful recruitment of a number of experienced scientists, both Mike's and
Robert's extensive specialisms reinforce Molecular Profile's commitment to enhancing
our in-house expertise and service offering."

Molecular Profiles' services can be broadly categorised into three key areas:
formulation support (including pre-formulation and product R&D); rapid problem
solving (during pre-formulation right through to manufacturing); and patent and
litigation support. Molecular Profiles have a range of expert witnesses who lead
multidisciplinary teams that can attest to international experience of deposition
and trial testimony in support of litigation issues.



Web Site: http://www.molprofles.co.uk

Contact Details: More information about Molecular Profiles' award-winning services
is available at www.molprofiles.co.uk, by e-mail at enquiry@molprofiles.co.uk,
alternatively, call Dr. Nikin Patel on +44 115 8718888.